Literature DB >> 22524208

Transcription factor 7-like 2 gene polymorphisms and gestational diabetes mellitus.

Katharina Klein1, Peter Haslinger, Dagmar Bancher-Todesca, Heinz Leipold, Martin Knöfler, Ammon Handisurya, Alexandra Kautzky-Willer, Christof Worda.   

Abstract

OBJECTIVE: Transcription factor 7-like 2 (TCF7L2) gene polymorphisms were shown to be associated with insulin resistance. We examined two single nucleotide exchanges in this gene in women with gestational diabetes mellitus (GDM) and in women with normal glucose tolerance.
METHODS: A total of 1800 unselected women were prospectively screened for GDM by oral glucose tolerance test (OGTT) between 24 and 28 weeks of gestation. Two hundred and fifty Caucasian women of this collective, 125 patients with pathological OGTT and 125 patients with normal glucose tolerance were randomly selected. DNA samples were isolated and TCF7L2 gene polymorphisms (TCF7L2rs12255372 and TCF7L2rs7903146) were analyzed.
RESULTS: Women with GDM were significantly older (30.1 ± 3.4 years vs. 28.2 ± 4.8 years, p = 0.01), had a significantly higher body mass index (26.4 kg/m(2); interquartile range: 23.33-31.19 vs. 24.6 kg/m(2); interquartile range: 21.05-27.28, p = 0.02) and were significantly more often homozygous for the T allele of TCF7L2rs12255372 (17.2% vs. 2.6%, p = 0.002) than patients with normal glucose tolerance. Binary logistic regression analysis showed that the homozygous variant of TCF7L2rs12255372 (T/T) is an independent risk factor for GDM (OR 7.7, 95% CI: 1.71-34.60), but not the homozygous variant of TCF7L2rs7903146 (T/T).
CONCLUSIONS: TCF7L2rs12255372 variant (T/T) is associated with increased risk of GDM in Caucasian women.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22524208     DOI: 10.3109/14767058.2012.663831

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  7 in total

1.  TCF7L2 rs7903146 polymorphism modulates the association between adherence to a Mediterranean diet and the risk of gestational diabetes mellitus.

Authors:  Ana Barabash; Johanna D Valerio; Nuria Garcia de la Torre; Inés Jimenez; Laura Del Valle; Verónica Melero; Carla Assaf-Balut; Manuel Fuentes; Elena Bordiu; Alejandra Durán; Miguel A Herraiz; Nuria Izquierdo; María J Torrejón; Paz de Miguel; Isabelle Runkle; Miguel A Rubio; Alfonso L Calle-Pascual
Journal:  Metabol Open       Date:  2020-11-26

2.  Transcription Factor 7-Like 2 (TCF7L2) rs7903146 Polymorphism as a Risk Factor for Gestational Diabetes Mellitus: A Meta-Analysis.

Authors:  Pei-Chao Lin; Wei-Ting Lin; Yao-Hsien Yeh; Shu-Fen Wung
Journal:  PLoS One       Date:  2016-04-08       Impact factor: 3.240

3.  Association between TCF7L2 polymorphisms and gestational diabetes mellitus: A meta-analysis.

Authors:  Shaoyan Chang; Zhen Wang; Lihua Wu; Xiaolin Lu; Shaofang Shangguan; Yu Xin; Li Li; Li Wang
Journal:  J Diabetes Investig       Date:  2017-02-28       Impact factor: 4.232

Review 4.  Genomics and Epigenomics of Gestational Diabetes Mellitus: Understanding the Molecular Pathways of the Disease Pathogenesis.

Authors:  Nadia Abu Samra; Herbert F Jelinek; Habiba Alsafar; Farah Asghar; Muhieddine Seoud; Shahad M Hussein; Hisham M Mubarak; Siddiq Anwar; Mashal Memon; Nariman Afify; Ridda Manzoor; Zahrah Al-Homedi; Wael Osman
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

Review 5.  Genetic variants associated with gestational diabetes mellitus: a meta-analysis and subgroup analysis.

Authors:  Ling Wu; Long Cui; Wing Hung Tam; Ronald C W Ma; Chi Chiu Wang
Journal:  Sci Rep       Date:  2016-07-29       Impact factor: 4.379

6.  Association of transcription factor 7-like 2 (TCF7L2) gene polymorphism with type 2 diabetes mellitus in Chinese Korean ethnicity population.

Authors:  Kui-Chen Zhou; Hong-Wei Liu; Chen Wang; Yan-Jun Fu; Feng Jin
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

7.  A Clinical Update on Gestational Diabetes Mellitus.

Authors:  Arianne Sweeting; Jencia Wong; Helen R Murphy; Glynis P Ross
Journal:  Endocr Rev       Date:  2022-09-26       Impact factor: 25.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.